DifluprednateFDA Approved: * August 9, 2021
Pharm Company: * CIPLA
Category: Vision / Eye Health
Difluprednate is a corticosteroid, It is chemically a butyrate ester of 6(alpha),9(alpha)-difluoro prednisolone acetate. Accordingly, difluprednate is sometimes abbreviated DFBA, for difluoroprednisolone butyrate acetate. Approval On June 24, 2008, the US Food and Drug Administration (FDA) approved difluprednate for the treatment of post-operative ocular inflammation and pain. It is marketed by Alcon under the tradename Durezol. Clinical trials Difluprednate ophthalmi... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.
Difluprednate Ophthalmic Emulsion Ophthalmic Emulsion .5 mg/ml Ophthalmic EmulsionNDC: 43598-588
Dr. Reddy's Laboratories Inc.
Difluprednate .5 mg/ml Ophthalmic EmulsionNDC: 69097-341
Cipla USA Inc.
Difluprednate .5 mg/ml Ophthalmic EmulsionNDC: 69238-1380
Amneal Pharmaceuticals Ny LLC
Difluprednate .5 mg/ml Ophthalmic EmulsionNDC: 76282-708
Exelan Pharmaceuticals, Inc.